Drug Name:
ATRAPRO ANTIPRURITIC HYDROGEL Rx
Generic Name and Formulations:
Sodium lithium magnesium fluorosilicate, dimethicone, sodium phosphate, sodium bicarbonate, sodium chloride, sodium sulfate, water, hypochlorus acid, sodium hypochlorite; topical gel.
Company:
Exeltis USA
Therapeutic Use:
Indications for ATRAPRO ANTIPRURITIC HYDROGEL:
To manage and relieve the pain, burning and itching associated with various dermatoses, including atopic and radiation dermatitis. May be used to relieve pain of first and second degree burns.
Adult:
Apply to affected area 3 times daily (or as needed). Allow to dry. Bandage as needed.
Children:
Not recommended.
Warnings/Precautions:
Avoid contact with eyes. Discontinue if sensitivity or chemical irritation occurs.
Pharmacological Class:
Antipruritic (nonsteroidal).
How Supplied:
Gel—4oz
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Are Vaccines Associated With Multiple Sclerosis Relapse?
- The Symbiosis of Headache and Sleep
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Neurosurgery in Parkinson Disease: A Brief History and Look Forward
- Blood Pressure-Dementia Link May Be Affected by Population Characteristics
- The Consequences of Compensation in Autism
- Adjunctive Eslicarbazepine Safe and Well Tolerated for Pediatric Seizures
- Erenumab Shown to Reduce Headache Days for Patients with Episodic Migraine
- New Zolmitriptan Intracutaneous System Safe and Effective for Migraine
- DBS Improves Inpatient Outcomes for Comorbid Parkinson Disease and Depression
- Treatment-Emergent Adverse Events With Adjunctive Eslicarbazepine Acetate in Pediatric Epilepsy